SDC1 and hepatocellular carcinoma: In fact, elevated amounts of shed syndecan-1 can be detected in the sera of patients with HCC as compared with healthy controls, and serum levels of shed syndecan-1 showed a positive correlation with the Barcelona Clinic Liver Cancer staging system, less favorable overall survival, and a greater risk of tumor recurrence and death [17,18].